Technology | April 11, 2013

ICU Medical Launches CardioFlo Minimally Invasive Hemodynamic Monitoring Sensor System

CardioFlo is shown in clinical testing to provide accurate, reliable and cost-effective hemodynamic monitoring


April 11, 2013 — ICU Medical Inc. has launched the CardioFlo hemodynamic monitoring sensor system. CardioFlo is a minimally invasive hemodynamic monitoring sensor system that, when used with an existing arterial catheter and connected to an Edwards Lifesciences Vigileo monitor, provides accurate and reliable hemodynamic monitoring data and an average of 40 percent cost savings over the Edwards Lifesciences FloTrac sensor.

CardioFlo facilitates the real-time assessment of hemodynamic and cardiovascular status, helping guide clinical decision-making and effective management of critically ill patients. In clinical testing, the level of agreement between the hemodynamic data provided by the Edwards Lifesciences FloTrac and the ICU Medical CardioFlo sensor systems was within 1 percent. As a result, CardioFlo provides a cost-effective alternative to the FloTrac sensor without sacrificing accuracy or reliability.

CardioFlo is available with the SafeSet closed blood sampling system, which allows clinicians to reduce blood discard waste during diagnostic phlebotomy by reinfusing it to the patient.

For more information: www.icumed.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now